10 exam-relevant updates · Organised for UPSC, SSC, Banking & Railway exams
Shows significant progress in preventing skin cancer recurrence using mRNA-based tailored vaccines in global trials.
Exam perspective
UPSC frequently tests emerging biotechnology breakthroughs and their applications beyond traditional medicine. Expect Prelims MCQs on: "What is a personalized cancer vaccine?" or "Which technology platform combines mRNA with immunotherapy?" Mains may ask: "Discuss the potential of mRNA-based therapeutic vaccines in oncology and India's preparedness in this biotech sector" (GS3 — Science & Technology innovation).
UPSC frequently tests emerging biotechnology breakthroughs and their applications beyond traditional medicine. Expect Prelims MCQs on: "What is a personalized cancer vaccine?" or "Which technology platform combines mRNA with immunotherapy?" Mains may ask: "Discuss the potential of mRNA-based therapeutic vaccines in oncology and India's preparedness in this biotech sector" (GS3 — Science & Technology innovation).
UPSC probes accessibility and cost barriers—personalized cancer vaccines are expensive, raising healthcare equity questions for developing nations like India. Regulatory challenges exist: India's drug approval pathway for complex biologics needs strengthening. Patent monopolies and technology transfer gaps between developed and developing nations are critical governance issues.
Cancer burden in India is rising; advanced therapeutic solutions are essential for public health policy. Developing indigenous mRNA vaccine capabilities strengthens India's biotech sovereignty and reduces dependence on imported oncology treatments.
📝 Exam Keywords
Daily Practice & Revision
Read updates, reinforce key figures with flashcards, and test recall with the daily quiz.
Go through all 10 exam updates and their key takeaways.
Active recall cards to reinforce dates, names and critical data.
10 exam-level MCQs with instant explanations to test recall.